Literature DB >> 1932878

Cannabis psychosis following bhang ingestion.

H R Chaudry1, H B Moss, A Bashir, T Suliman.   

Abstract

The purpose of this preliminary investigation is to systematically characterize the signs and symptoms of cannabis psychosis in individuals who presented for psychiatric treatment in Pakistan after ingestion of bhang; a beverage containing cannabis. In order to control for the behavioral effects of cannabis alone, symptoms produced by bhang ingestion among non-patients consuming the same beverage were compared with those symptoms found among psychotic patients. Patients differed from controls in that a higher proportion of patients were found to be chronic users of bhang, and had a past history of psychotic episodes. Presenting symptoms of bhang-induced psychosis found in patients included grandiosity, excitement, hostility, uncooperativeness, disorientation, hallucinatory behavior and unusual thought content. Neuroleptic treatment successfully attenuated psychotic symptoms within five days of the initiation of the episode. The presenting symptoms of bhang-induced psychosis are consistent with a brief mania-like disorder with paranoid psychotic features, and cognitive dysfunction. Several etiologic hypotheses are proposed.

Entities:  

Mesh:

Year:  1991        PMID: 1932878     DOI: 10.1111/j.1360-0443.1991.tb01874.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  17 in total

1.  Cannabis Use in Psychiatrie Patients.

Authors:  S Chaudhury; S Sudarsanan; S K Salujha; K Srivastava
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Cannabis related psychiatric syndromes: a selective review.

Authors:  D Basu; A Malhotra; V K Varma
Journal:  Indian J Psychiatry       Date:  1994-07       Impact factor: 1.759

3.  (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population.

Authors:  Isabel Martínez-Gras; Janet Hoenicka; Guillermo Ponce; Roberto Rodríguez-Jiménez; Miguel Angel Jiménez-Arriero; Elena Pérez-Hernandez; Israel Ampuero; Jose Antonio Ramos-Atance; Tomas Palomo; Gabriel Rubio
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-20       Impact factor: 5.270

4.  Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.

Authors:  Erin L Karschner; David M Schwope; Eugene W Schwilke; Robert S Goodwin; Deanna L Kelly; David A Gorelick; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2012-03-29       Impact factor: 4.492

Review 5.  Cannabis-associated psychosis: current status of research.

Authors:  F Markus Leweke; Christoph W Gerth; Joachim Klosterkötter
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  Impact of Cannabis Use on the Development of Psychotic Disorders.

Authors:  Samuel T Wilkinson; Rajiv Radhakrishnan; Deepak Cyril D'Souza
Journal:  Curr Addict Rep       Date:  2014-06-01

7.  Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90).

Authors:  Icro Maremmani; Pier Paolo Pani; Matteo Pacini; Jacopo V Bizzarri; Emanuela Trogu; Angelo Gi Maremmani; Gilberto Gerra; Giulio Perugi; Liliana Dell'Osso
Journal:  Ann Gen Psychiatry       Date:  2010-04-13       Impact factor: 3.455

8.  Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers.

Authors:  David A Gorelick; Robert S Goodwin; Eugene Schwilke; David M Schwope; William D Darwin; Deanna L Kelly; Robert P McMahon; Fang Liu; Catherine Ortemann-Renon; Denis Bonnet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2012-10-16       Impact factor: 3.367

Review 9.  Gene-environment interplay between cannabis and psychosis.

Authors:  Cécile Henquet; Marta Di Forti; Paul Morrison; Rebecca Kuepper; Robin M Murray
Journal:  Schizophr Bull       Date:  2008-08-22       Impact factor: 9.306

10.  Cannabis and psychopathology : update 2004.

Authors:  Sandeep Grover; Debasish Basu
Journal:  Indian J Psychiatry       Date:  2004-10       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.